ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500672 announcements Novartis announcements and dividends declared BSE

Novartis Complete list of announcements declared & dividend announcements by Novartis 500672

Novartis 500672 listed on BSE and deals in

Announcements and dividends declared by Novartis 500672

In major move, patent of Novartis' blockbuster cardiac drug revoked by India
The Indian Patent Office revoked Novartis' patent for Vymada, a heart failure drug, citing a lack of novelty and inventive step. This decision paves the way for generic versions, potentially lowering treatment costs for Indian patients. Domestic pharmaceut
Announcement as on 16 September 2025

Novartis' Moonshot Cancer Therapy Could Be Future Growth Driver
GLP-1 drugs are taking much oxygen out of the biotechnology trade. However, many investors have been eyeing other areas in the sector, particularly cancer research. Novartis AG (NYSE: NVS) is up over 31% in 2025, and a novel cancer treatment could giv
Announcement as on 09 September 2025

Novartis offers payment plan for high-cost heart medicine
Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden access by offering zero-interest EMI options. This strategy addresses the drug's high cost, previously ₹1.2 lakh pe
Announcement as on 27 May 2025

Market volatility derails Novartis' plan to sell stake in its India arm
Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strategic reviews and potential interest, fluctuations in stock prices and declining sales present hurdles in reaching a de
Announcement as on 01 April 2025

PTC Inks License And Collaboration Deal With Novartis For PTC518 Huntington's Disease Program
(RTTNews) - Biopharmaceutical company PTC Therapeutics, Inc. (PTCT) announced Monday the signing of an exclusive global license and collaboration agreement with Novartis Pharmaceuticals Corp., a subsidiary of Novartis AG (NVS), for its PTC518 Huntington's
Announcement as on 02 December 2024

Announcements by Novartis first page | Next page | Prev page |

500672 Novartis current price & indicator signals

Moving Averages for Novartis

  • 5Day Average: 1197.73
  • 12Day Average: 1107.06
  • 20Day Average: 1058.99
  • 50Day Average: 997
  • 100Day Average: 903.07
  • 150Day Average: 881.74
  • 200Day Average: 895.89

500672 Indicators & signals

Indicator MACD (12,26,9)

1126.79, 1065.69, 41.24
Indicator MACD is in positive zone

Indicator ADX (14)

61.43, 34.85, 8.33
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500672 Novartis are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Thu May 2026 1191.85 1184.00 to 1272.60 -4.05% 0.67 times
13 Wed May 2026 1242.20 1211.00 to 1265.80 -1.34% 0.59 times
12 Tue May 2026 1259.05 1156.70 to 1275.00 6.43% 4.47 times
11 Mon May 2026 1182.95 1092.50 to 1243.60 6.32% 3.12 times
08 Fri May 2026 1112.60 1067.10 to 1121.10 4.43% 0.74 times
07 Thu May 2026 1065.45 1045.00 to 1072.95 1.4% 0.22 times
06 Wed May 2026 1050.70 1035.05 to 1056.95 1.21% 0.28 times
05 Tue May 2026 1038.10 1015.00 to 1040.05 1.59% 0.11 times
04 Mon May 2026 1021.90 1011.05 to 1032.90 -1.06% 0.11 times
30 Thu Apr 2026 1032.90 1014.50 to 1039.25 -0.12% 0.1 times
29 Wed Apr 2026 1034.10 1025.35 to 1062.00 -1.79% 0.27 times
28 Tue Apr 2026 1052.95 984.30 to 1057.00 7.5% 1.49 times

Videos related to: 500672 announcements Novartis announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500672 announcements Novartis announcements and dividends declared BSE

 

Back to top